- Home
- TNYA vs FT Comparison
TNYA vs FT Comparison
Compare TNYA & FT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TNYA
- FT
- Stock Information
- Founded
- TNYA 2016
- FT 1988
- Country
- TNYA United States
- FT United States
- Employees
- TNYA N/A
- FT N/A
- Industry
- TNYA Medicinal Chemicals and Botanical Products
- FT Trusts Except Educational Religious and Charitable
- Sector
- TNYA Health Care
- FT Finance
- Exchange
- TNYA Nasdaq
- FT Nasdaq
- Market Cap
- TNYA 189.1M
- FT 192.5M
- IPO Year
- TNYA 2021
- FT N/A
- Fundamental
- Price
- TNYA $1.07
- FT $7.91
- Analyst Decision
- TNYA Strong Buy
- FT
- Analyst Count
- TNYA 5
- FT 0
- Target Price
- TNYA $8.60
- FT N/A
- AVG Volume (30 Days)
- TNYA 4.0M
- FT 63.0K
- Earning Date
- TNYA 08-06-2025
- FT 01-01-0001
- Dividend Yield
- TNYA N/A
- FT 7.85%
- EPS Growth
- TNYA N/A
- FT N/A
- EPS
- TNYA N/A
- FT N/A
- Revenue
- TNYA N/A
- FT N/A
- Revenue This Year
- TNYA N/A
- FT N/A
- Revenue Next Year
- TNYA N/A
- FT N/A
- P/E Ratio
- TNYA N/A
- FT N/A
- Revenue Growth
- TNYA N/A
- FT N/A
- 52 Week Low
- TNYA $0.36
- FT $5.97
- 52 Week High
- TNYA $4.01
- FT $7.23
- Technical
- Relative Strength Index (RSI)
- TNYA 61.05
- FT 54.19
- Support Level
- TNYA $0.90
- FT $7.81
- Resistance Level
- TNYA $1.45
- FT $8.00
- Average True Range (ATR)
- TNYA 0.13
- FT 0.09
- MACD
- TNYA 0.03
- FT -0.02
- Stochastic Oscillator
- TNYA 52.74
- FT 38.46
About TNYA Tenaya Therapeutics Inc.
Tenaya Therapeutics Inc is a preclinical stage biotechnology company focused on discovering, developing, and delivering curative therapies that address the underlying drivers of heart disease. It is advancing product candidates from three product platforms: gene therapy, cellular regeneration and precision medicine.
About FT Franklin Universal Trust
Franklin Universal Trust is a closed-end management investment company. Its primary investment objective is to provide high, current income consistent with the preservation of capital. Its secondary objective is the growth of income through dividend increases and capital appreciation. The fund invests in two asset classes being the high yield bonds and utility stocks.